Crossmark Global Holdings’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$357K Sell
11,981
-274
-2% -$8.41K ﹤0.01% 978
2026
Q2
$425K Buy
12,255
+438
+4% +$11.8K 0.01% 928
2026
Q1
$245K Hold
11,817
– – ﹤0.01% 1114
2025
Q4
$384K Buy
11,817
+152
+1% +$6.51K 0.01% 936
2025
Q3
$662K Buy
11,665
+605
+5% +$31K 0.01% 782
2025
Q2
$551K Buy
11,060
+639
+6% +$28.9K 0.01% 844
2025
Q1
$308K Buy
+10,421
New +$387K 0.01% 1074

Other funds holding HIMS

Crossmark Global Holdings's HIMS Position: Q3 2026 in Review

Crossmark Global Holdings reduced its Hims & Hers Health (HIMS) stake by 2.2% in Q3 2026, selling an estimated $8.41K and leaving 11,981 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

Crossmark Global Holdings first reported a position in HIMS in Q1 2025 and has held it in 7 quarters since. The position peaked at $662K in Q3 2025. 58 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Crossmark Global Holdings held 11,981 shares of Hims & Hers Health worth $357K as of Q3 2026.
  • Crossmark Global Holdings sold 274 Hims & Hers Health shares in Q3 2026, an estimated $8.41K.
  • Hims & Hers Health made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q3 2026, its #978 holding.
  • Crossmark Global Holdings first reported a position in Hims & Hers Health in Q1 2025 and has held it in 7 quarters since.
  • Crossmark Global Holdings's Hims & Hers Health position peaked at $662K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.